Cigarette smoking and rheumatoid arthritis severity. 1997

K G Saag, and J R Cerhan, and S Kolluri, and K Ohashi, and G W Hunninghake, and D A Schwartz
Division of Rheumatology, University of Iowa College of Medicine, Iowa City 52242-1087, USA.

OBJECTIVE Cigarette smoking may influence rheumatoid arthritis (RA) disease incidence and may have direct biological effects on the lungs and systemically. This study sought to determine if cigarette smoking is associated with RA disease severity. METHODS Clinical evaluations of patients seen in the University of Iowa rheumatology and orthopaedic ambulatory clinics were conducted. A letter of interest was mailed to 1701 patients who were first assigned an ICD-9-CM diagnostic code for RA in one of these clinics. A total of 857 patients expressed interest and were offered a clinical examination and 395 were evaluated over an 18 month period. Of these, 336 satisfied examiner criteria for prevalent RA and were included in the analysis. The disease characteristics and arthritis care utilisation of these patients seemed representative of prevalent cases in the general community. RA disease severity was assessed by radiographic bone erosions (graded as either present/ absent and using the Larsen system), rheumatoid factor seropositivity, and presence of subcutaneous rheumatoid nodules. RESULTS Pack years of cigarette smoking was significantly associated with rheumatoid factor seropositivity (p = 0.0001), radiographic erosions (p = 0.024), and nodules (p = 0.051). After adjustment for potential confounders, smokers with > or = 25 pack years were 3.1 times more likely to be rheumatoid factor positive (95% CI 1.7, 5.6) and 2.4 times more likely to show radiographic erosions (95% CI 1.2, 4.5) than never smokers. Less severe radiographic disease seemed to be more strongly associated with cigarette smoking than more severe disease. CONCLUSIONS Cigarette smoking may adversely influence the severity of RA in a potentially dose dependent fashion.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D001172 Arthritis, Rheumatoid A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated. Rheumatoid Arthritis
D001175 Arthrography Roentgenography of a joint, usually after injection of either positive or negative contrast medium. Arthrographies
D012217 Rheumatoid Factor Autoantibodies found in adult RHEUMATOID ARTHRITIS patients that are directed against GAMMA-CHAIN IMMUNOGLOBULINS. Factor, Rheumatoid
D012218 Rheumatoid Nodule Subcutaneous nodules seen in 20-30% of rheumatoid arthritis patients. They may arise anywhere on the body, but are most frequently found over the bony prominences. The nodules are characterized histologically by dense areas of fibrinoid necrosis with basophilic streaks and granules, surrounded by a palisade of cells, mainly fibroblasts and histiocytes. Rheumatoid Nodulosis,Nodule, Rheumatoid,Nodules, Rheumatoid,Rheumatoid Nodules,Rheumatoid Noduloses

Related Publications

K G Saag, and J R Cerhan, and S Kolluri, and K Ohashi, and G W Hunninghake, and D A Schwartz
December 2001, Rheumatology (Oxford, England),
K G Saag, and J R Cerhan, and S Kolluri, and K Ohashi, and G W Hunninghake, and D A Schwartz
December 2001, Seminars in arthritis and rheumatism,
K G Saag, and J R Cerhan, and S Kolluri, and K Ohashi, and G W Hunninghake, and D A Schwartz
January 2005, Clinical and experimental rheumatology,
K G Saag, and J R Cerhan, and S Kolluri, and K Ohashi, and G W Hunninghake, and D A Schwartz
November 2000, Rheumatology (Oxford, England),
K G Saag, and J R Cerhan, and S Kolluri, and K Ohashi, and G W Hunninghake, and D A Schwartz
August 2007, Annals of the rheumatic diseases,
K G Saag, and J R Cerhan, and S Kolluri, and K Ohashi, and G W Hunninghake, and D A Schwartz
November 2008, Annals of the rheumatic diseases,
K G Saag, and J R Cerhan, and S Kolluri, and K Ohashi, and G W Hunninghake, and D A Schwartz
January 1998, Rheumatology international,
K G Saag, and J R Cerhan, and S Kolluri, and K Ohashi, and G W Hunninghake, and D A Schwartz
December 2009, Inflammation & allergy drug targets,
K G Saag, and J R Cerhan, and S Kolluri, and K Ohashi, and G W Hunninghake, and D A Schwartz
June 2008, The Journal of rheumatology,
K G Saag, and J R Cerhan, and S Kolluri, and K Ohashi, and G W Hunninghake, and D A Schwartz
January 2014, Clinical laboratory,
Copied contents to your clipboard!